title: SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progression.
abstract: Adipocyte dysfunction correlates with the development of diabetes. Here we show that mice with a adipocyte-specific deletion of the SUMO-specific protease SENP1 gene develop symptoms of type-1 diabetes mellitus (T1DM), including hyperglycaemia and glucose intolerance with mild insulin resistance. Peri-pancreatic adipocytes from SENP1-deficient mice exhibit heightened NF-κB activity and production of proinflammatory cytokines, which induce CCL5 expression in adjacent pancreatic islets and direct cytotoxic effects on pancreatic islets. Mechanistic studies show that SENP1 deletion in adipocytes enhances SUMOylation of the NF-κB essential molecule, NEMO, at lysine 277/309, leading to increased NF-κB activity, cytokine production and pancreatic inflammation. We further show that NF-κB inhibitors could inhibit pre-diabetic cytokine production, β-cell damages and ameliorate the T1DM phenotype in SENP1-deficient mice. Feeding a high-fat diet augments both type-1 and type-2 diabetes phenotypes in SENP1-deficient mice, consistent with the effects on adipocyte-derived NF-κB and cytokine signalling. Our study reveals previously unrecognized mechanism regulating the onset and progression of T1DM associated with adipocyte dysfunction.
authors.affiliation: The First Affiliated Hospital, Center for Translational Medicine, Sun Yat-sen University, Guangzhou, China.|Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St, New Haven, Connecticut 06520, USA.
authors.forename: Lan
authors.initials: L
authors.lastname: Shao
authors.affiliation: Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St, New Haven, Connecticut 06520, USA.
authors.forename: Huanjiao Jenny
authors.initials: HJ
authors.lastname: Zhou
authors.affiliation: Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St, New Haven, Connecticut 06520, USA.
authors.forename: Haifeng
authors.initials: H
authors.lastname: Zhang
authors.affiliation: Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St, New Haven, Connecticut 06520, USA.
authors.forename: Lingfeng
authors.initials: L
authors.lastname: Qin
authors.affiliation: Department of Internal Medicine and Section of Cardiology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
authors.forename: John
authors.initials: J
authors.lastname: Hwa
authors.affiliation: Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
authors.forename: Zhong
authors.initials: Z
authors.lastname: Yun
authors.affiliation: The First Affiliated Hospital, Center for Translational Medicine, Sun Yat-sen University, Guangzhou, China.
authors.forename: Weidong
authors.initials: W
authors.lastname: Ji
authors.affiliation: The First Affiliated Hospital, Center for Translational Medicine, Sun Yat-sen University, Guangzhou, China.|Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St, New Haven, Connecticut 06520, USA.
authors.forename: Wang
authors.initials: W
authors.lastname: Min
mesh_terms: D041721:3T3-L1 Cells; D017667:Adipocytes / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D018946:Chemokine CCL5 / Q000276:immunology; D047369:Chromatin Immunoprecipitation; D003546:Cysteine Endopeptidases; D016207:Cytokines / Q000276:immunology / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000276:immunology; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000276:immunology; D059305:Diet, High-Fat; D010450:Endopeptidases / Q000235:genetics* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D055786:Gene Knockout Techniques; D018149:Glucose Intolerance / Q000235:genetics / Q000276:immunology; D006943:Hyperglycemia / Q000235:genetics / Q000276:immunology; D015151:Immunoblotting; D047468:Immunoprecipitation; D007249:Inflammation; D007333:Insulin Resistance / Q000235:genetics / Q000276:immunology; D050417:Insulin-Secreting Cells / Q000276:immunology / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins / Q000276:immunology / Q000378:metabolism*; D007515:Islets of Langerhans / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D016297:Mutagenesis, Site-Directed; D016328:NF-kappa B / Q000276:immunology / Q000378:metabolism*; D010641:Phenotype; D020133:Reverse Transcriptase Polymerase Chain Reaction; D025841:Small Ubiquitin-Related Modifier Proteins
chemical_list: C503460:Ccl5 protein, mouse; D018946:Chemokine CCL5; D016207:Cytokines; D047908:Intracellular Signaling Peptides and Proteins; C514981:NEMO protein, mouse; D016328:NF-kappa B; D025841:Small Ubiquitin-Related Modifier Proteins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; C501974:Senp1 protein, mouse